![]() |
>> Phillip Castle
Investigator, National Cancer Institute, National Institutes of Health
Bethesda, USA
|
Dr. Castle received his Ph.D. in Biophysics from the Johns Hopkins University (JHU) in 1995. Dr. Castle then did a post-doctoral fellowship at the NIH on the molecular biology of the zona pellucida. In 1999, he joined the Cancer Prevention Fellowship at NCI and received his MPH from JHU in 2000. He conducted his Cancer Prevention Fellowship training with NCI's Hormonal and Reproductive Epidemiology Branch (2000-2003) and joined the branch as a principal investigator in 2003. His professional interests are (1) epidemiology of human papillomaviruses (HPV) and cervical/anogenital cancer; and (2) science and translation of cancer prevention strategies. He is the lead investigator on several epidemiologic studies, including the Mississippi Delta Project, The HPV Persistence and Progression Cohort at Kaiser Permanente Northern California, and the Low-Cost Molecular Cervical Cancer Screening Study in China. |
>> Lectures by Phillip Castle
| Date | Start - End Time | Name | Room | Action |
|---|---|---|---|---|
| Saturday, July 3, 2010 | 12:00 PM - 12:30 PM | A risk-based model for integrating new technologies, including HPV vaccination and new biomarkers, into cervical cancer prevention programs | Add to my agenda | |
| Saturday, July 3, 2010 | 01:15 PM - 01:30 PM | HPV testing for the triage of ASCUS and LSIL; principles and results | 517a |
Add to my agenda |
| Saturday, July 3, 2010 | 04:15 PM - 04:30 PM | Closing Comments | 517a |
Add to my agenda |
| Monday, July 5, 2010 | 04:50 PM - 05:00 PM | Summary | 515ab |
Add to my agenda |
| Tuesday, July 6, 2010 | 08:30 AM - 09:00 AM | New Molecular Markers for Cervical Cancer Screening: Distinguishing Hype from Hope | 517cd |
Add to my agenda |
| Wednesday, July 7, 2010 | 07:00 AM - 08:15 AM | How to Manage a Research Team | 516bcd |
Add to my agenda |
